Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Yama Lea’s Shield Contraceptive Market Strategy To Focus On Convenience

This article was originally published in The Gray Sheet

Executive Summary

Yama, Inc. is positioning its Lea's Shield reusable barrier contraceptive device as "more convenient" than traditional diaphragms

You may also be interested in...



FemCap Barrier Contraceptive To Launch In May; Licensing Partner Sought

FemCap, Inc. is seeking to license its female barrier contraceptive to potential marketing partners to facilitate broad adoption of the product

FemCap Barrier Contraceptive To Launch In May; Licensing Partner Sought

FemCap, Inc. is seeking to license its female barrier contraceptive to potential marketing partners to facilitate broad adoption of the product

Lea’s Shield Clinical Investigator Warned For Improper Informed Consent

Informed consent and records violations by clinical investigator Mitchell Creinin, MD, University of Pittsburgh, during the pivotal trial for Yama, Inc.'s Lea's Shield were significant enough to draw a warning letter, but did not hinder approval of the PMA

UsernamePublicRestriction

Register

OM013195

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel